門脈高壓
門脈高壓(英語:Portal hypertension)為描述肝門靜脈系統高壓的狀態。目前的定義為肝門靜脈梯度高於或等於6mmHg[1]。門脈高壓最常見的原因就是肝硬化,其他較罕見的原因則稱為非肝硬化性門脈高壓(non-cirrhotic portal hypertension)。當門脈高壓已造成問題,則必須適當紓解門脈壓力[來源請求]。
門脈高壓 | |
---|---|
The portal vein and its tributaries | |
症狀 | 腹水、黃疸、脾腫大[*]、微血管擴張 |
類型 | hepatic vascular disease[*]、高血壓[*]、疾病 |
病因 | 門靜脈血栓[*]、血吸蟲病、肝硬化、限制型心肌病[*]、心包炎 |
分類和外部資源 | |
醫學專科 | Gastroenterology |
ICD-11 | DB98.7 |
ICD-9-CM | 572.3 |
DiseasesDB | 10388 |
eMedicine | 182098 |
症狀和徵象
編輯門脈高壓的症狀和徵象包含:
病因
編輯門脈高壓可藉由病灶發生的位置分為肝前性、肝內性、肝後性等。最常見的因素為肝硬化,其他原因則包含[2][5][6]:
非肝硬化性門脈高壓的相關因子 | |
---|---|
肝前性 | 門靜脈或脾靜脈血栓 |
動靜脈瘻管 | |
脾腫大(增加門脈血流) | |
肝內性 | 所有造成肝硬化的原因,包含酗酒、慢性病毒性肝炎、膽道閉鎖等等 |
Primary biliary cirrhosis | |
Primary sclerosing cholangitis | |
Chronic pancreatitis | |
Hereditary haemorrhagic telangiectasia | |
血吸蟲症 | |
Congenital hepatic fibrosis | |
Nodular regenerative hyperplasia | |
Fibrosis of space of Disse | |
Granulomatous or infiltrative liver diseases (Gaucher, mucopolysaccharidosis, sarcoidosis, lymphoproliferative malignancies, amyloid deposition, …) | |
毒素(如砷、銅、氯乙烯、礦物油、維生素A、azathioprine、dacarbazine、methotrexate、amiodarone...) | |
病毒性肝炎 | |
脂肪肝 | |
Veno-occlusive disease | |
肝後性 | 下腔靜脈阻塞 |
(Right-sided) heart failure, e.g. from constrictive pericarditis | |
布加症候群 | |
Budd-Chiari syndrome |
病生理
編輯門脈高壓的直接原因主要是血管的阻力增加,但造成血管阻力增加的原因則相當多樣。一般來說還會合併星狀細胞及肌成纖維細胞活化。內源性血管擴張劑也可能導致靜脈血流增加[2][7]。
參考文獻
編輯- ^ Portal hypertension | Disease | Overview | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. rarediseases.info.nih.gov. [2016-01-08]. (原始內容存檔於2016-01-27).
- ^ 2.0 2.1 2.2 2.3 2.4 Portal Hypertension. Learn about Portal Hypertension | Patient. Patient. [2016-01-08]. (原始內容存檔於2021-01-19) (英國英語).
- ^ Spontaneous Bacterial Peritonitis. www.karger.com. [2016-01-08]. (原始內容存檔於2020-05-10).
- ^ Sun, Z; Migaly, J. Review of Hemorrhoid Disease: Presentation and Management.. Clinics in colon and rectal surgery. March 2016, 29 (1): 22–9. PMID 26929748. doi:10.1055/s-0035-1568144.
- ^ Bloom, S.; Kemp, W.; Lubel, J. Portal hypertension: pathophysiology, diagnosis and management. Internal Medicine Journal. 2015-01-01, 45 (1): 16–26 [2017-01-03]. ISSN 1445-5994. doi:10.1111/imj.12590. (原始內容存檔於2017-09-14).
- ^ Perkins, [edited by] Vinay Kumar, Abul K. Abbas, Jon C. Aster ; artist, James A. Robbins basic pathology 9th. Philadelphia, PA: Elsevier/Saunders. : 608. ISBN 978-1-4377-1781-5.2013
- ^ Portal Hypertension: Practice Essentials, Background, Anatomy. [2017-01-03]. (原始內容存檔於2021-05-06).
延伸閱讀
編輯- Garbuzenko D.V., Arefyev N.O., Belov D.V. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J. Hepatol. 2016; 8 (16): 665-672.
- Garbuzenko D.V. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Curr. Med. Res. Opin. 2016; 32 (3): 467-475.
- Garbuzenko D.V. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J. Gastroenterol. 2015; 21 (20): 6117-6126.
- Functional aspects on the pathophysiology of portal hypertension in cirrhosis – Journal of Hepatology. www.journal-of-hepatology.eu. [2016-01-08]. (原始內容存檔於2019-07-10).
- Rossi, Plinio. Portal Hypertension: Diagnostic Imaging and Imaging-Guided Therapy. Springer Science & Business Media. 2012-12-06 [2017-01-03]. ISBN 9783642571169. (原始內容存檔於2020-08-31).
- Imanieh, Mohammad Hadi; Dehghani, Seyed Mohsen; Khoshkhui, Maryam; Malekpour, Abdorrasoul. Etiology of Portal Hypertension in Children:A Single Center’s Experiences. Middle East Journal of Digestive Diseases. 2012-10-01, 4 (4): 206–210. ISSN 2008-5230. PMC 3990125 . PMID 24829658.
外部連結
編輯- Ascites at Merck Manual of Diagnosis and Therapy Home Edition
- Children's Liver Disease Foundation (頁面存檔備份,存於網際網路檔案館)